Caroline Germa

Caroline Germa is Chief Medical Officer of Triana Biosciences and a member of Transcenta’s Scientific Advisory Board. With more than 20 years of experience in the pharmaceutical and biotech industries, she has deep expertise in oncology.

Caroline previously held senior leadership roles in oncology clinical development at AstraZeneca, Bristol Myers Squibb and Novartis.

She holds a medical degree, and specialized in medical oncology at Paris Descartes and Lille Universities. She also holds a university degree in health economics from the Université Paris Cité.